Skip to content
DE

Vitamin K: blood levels, clotting and bone health

Clinical review pending

K1, K2 and functional markers explained clearly, with the limits of lab tests and important interactions.

What vitamin K is

Vitamin K is the name for a family of fat-soluble compounds. Vitamin K1, phylloquinone, is found mainly in leafy green vegetables. Vitamin K2 covers various menaquinones, such as MK-4 and MK-7, which occur in fermented foods and certain animal products, among other sources. The forms differ in how they are distributed and how long they stay in the body, but they share basic functions in activating vitamin K-dependent proteins.

Lab tests can measure circulating phylloquinone or look at certain functional consequences. PIVKA-II is undercarboxylated prothrombin. Incompletely carboxylated osteocalcin is used in the context of bone metabolism. These specialized markers are not an add-on that every health check automatically needs.

How vitamin K is involved in calcium binding

Vitamin K is needed for the gamma-carboxylation of certain proteins. This allows them to bind calcium and do their job. They include clotting factors, osteocalcin and matrix Gla protein. The often-repeated phrase that vitamin K “steers calcium into the bones and out of the arteries” oversimplifies these complex processes. The mechanism does not automatically mean that a supplement reverses vascular calcification or prevents fractures.

After taking part in the reaction, vitamin K is recycled, in part via VKORC1. Vitamin K antagonists such as warfarin interfere with this cycle. That is why larger changes in vitamin K intake can alter their anticoagulant effect. K1 is not responsible only for clotting, and K2 is not responsible only for bones or blood vessels; such a strict division would be misleading.

Observational studies such as the Rotterdam Study found links between higher menaquinone intake and lower coronary risk. Data like these do not prove cause. Intervention studies can improve functional markers, while data on clinical endpoints such as fractures or cardiovascular events remain mixed. A systematic review on bone health therefore also looks at bone density and fractures.

Reading a serum vitamin K value

For phylloquinone, reference ranges of about 0.2–3.2 ng/mL are used, for example. Reference ranges differ by lab and method. Because vitamin K is carried with lipoproteins and responds to meals, fasting, blood lipids and recently eaten food all change the value. A single level is not direct proof of optimal supply to all tissues.

High values

After a meal with plenty of leafy greens and fat, the level can rise. In the first instance this shows recent intake and does not automatically mean an overdose. In people taking vitamin K antagonists, an INR that is too low can point to insufficient anticoagulation; assessing this is a job for the treating practice. A high K level or a low INR outside this therapy does not, on its own, prove an increased tendency to thrombosis.

Low values

Low intake, fat malabsorption, certain liver or bile duct diseases and prolonged antibiotic therapy can be relevant. A prolonged clotting time or raised PIVKA-II can point to insufficiently activated clotting proteins, but these also have other possible explanations. Easy bruising, bleeding gums or persistent bleeding need to be investigated; they are not specific to vitamin K.

A low fasting value alone does not prove a deficiency. With celiac disease, pancreatic insufficiency, cholestasis, Crohn’s disease or after bariatric surgery, however, the risk of impaired absorption is higher. Functional markers can provide extra help in selected situations.

Normal values

A result within the reference range is one part of the assessment. It does not rule out every functional disorder, nor does it automatically make further tests necessary. Age, liver function, symptoms, medications and diet determine whether there is any further question to answer at all.

Why your last few meals affect the result

Vitamin K is fat-soluble and is carried in the blood bound to lipoproteins. Different sampling conditions can therefore create apparent changes. Comparison measurements should, where possible, be taken under documented, similar conditions.

When taking vitamin K antagonists, a relatively consistent diet is important. The goal is not to avoid green vegetables altogether; large swings or newly started supplements can change the INR. MK-7 stays in circulation longer than MK-4 and can affect functional markers for longer. That does not automatically mean a proven greater clinical benefit.

Fat absorption disorders and certain bariatric procedures can compromise vitamin K status despite adequate intake. Antibiotics alter gut bacteria, whose menaquinone production can contribute to the overall picture; this is especially relevant with longer courses and additional risks. Very low lipid levels can change circulating phylloquinone without that alone meaning a tissue deficiency. Lipid-lowering medications should therefore not be presented across the board as a cause of a vitamin K deficiency needing treatment.

Newborns are a special risk group: vitamin K crosses the placenta only to a limited extent, and their supply is limited at first. Vitamin K prophylaxis after birth serves to prevent vitamin K deficiency bleeding and should not be equated with general supplement recommendations for adults.

Which other markers can add to the picture

Calcium and vitamin D are important for specific questions about mineral and bone metabolism. Magnesium may be added depending on the situation. Alkaline phosphatase has various origins; a raised total ALP proves neither bone remodeling nor a vitamin K deficiency. Further tests are needed to pin down the source if required.

Lipid values help put a phylloquinone level in its transport context. Clotting tests, liver values and, where appropriate, bone density scans each follow their own clinical question. Combining all available markers is not automatically more useful than a targeted selection.

When to retest

Serum phylloquinone can change with intake within a short time. Functional markers respond over days to weeks. One possible window for a follow-up is four to eight weeks after a relevant change. This is not a general rule; the test, the cause and the treatment determine the timing.

With vitamin K antagonists, monitoring is guided by the INR and the individual treatment plan, not by a general vitamin K testing calendar. And not every other anticoagulant is managed using the INR. New supplements or larger dietary changes should therefore be coordinated with the prescribing practice.

When targeted investigation makes sense

Unusual bleeding, suspected fat malabsorption, certain liver diseases or particular postoperative risks can be reasons for testing. Simply eating more vegetables, on the other hand, does not normally call for specialized lab work alongside it. For bone health, adequate nutrition, physical activity, appropriate diagnostics and, where needed, established treatment remain what counts.

Frequently asked questions

What forms are there?

K1 comes mainly from green vegetables; K2 covers menaquinones such as MK-4 and MK-7. Both belong to the vitamin K family and have overlapping biological roles.

How does vitamin K work?

It enables the carboxylation of certain proteins, including clotting factors II, VII, IX and X, as well as osteocalcin and matrix Gla protein. A biological mechanism does not yet prove that any given supplement works against a disease.

What blood level is normal?

For K1, figures such as 0.2–3.2 ng/mL are given, depending on the lab. Meals and blood lipids affect the value; what counts is the specific lab result in its clinical context.

What causes a deficiency?

Mainly impaired fat absorption, very low intake combined with other risks, certain diseases and some treatment situations. Newborns have particular physiological risks.

Which symptoms are possible?

Bruising, nosebleeds or bleeding gums and prolonged bleeding can occur. They have many possible causes and do not justify self-diagnosis. Heavy or persistent bleeding needs prompt medical help.

Which interaction matters most?

Vitamin K can change the effect of vitamin K antagonists. Consistent intake and checking with your doctor before taking supplements are important. This does not apply in the same way to every class of anticoagulant medication.

Does vitamin K need to be tested every year?

No. Routine testing is not intended for everyone. Targeted tests can be useful when there is a relevant medical question; for people taking vitamin K antagonists, INR monitoring takes priority.

Is K2 better than K1 for the heart and bones?

MK-7 stays in the body longer and can affect certain functional markers. Observational data and individual studies are interesting, but they offer no general promise of fewer heart attacks or fractures. Clinical endpoints and the individual situation are what count for a decision.

Sources